Diabetes is the leading cause of chronic kidney disease (CKD) and is associated with
excessive cardiovascular morbidity and mortality (1, 2). Anemia is common among those …

In 2007, 1179 papers were published that involved the application of optical biosensors.
Reported developments in instrument hardware, assay design, and immobilization …

Renal anemia is a complication of chronic kidney disease. Guidelines for safe and effective
treatment in patients with renal anemia are needed. The Japanese Society for Dialysis …

Abstract The Japanese Society for Dialysis Therapy (JSDT) guideline committee, chaired by
Dr Y. Tsubakihara, presents the Japanese guidelines entitled “Guidelines for Renal Anemia …

Purpose Following two cases of neutralizing antibodies to epoetin alfa in an investigational
clinical study, a small number of individual syringes of two drug product batches were found …

Background We investigated whether a novel, synthetic, peptide-based erythropoietin-
receptor agonist (Hematide, Affymax) can stimulate erythropoiesis in patients with anemia …

Abstract Background Subcutaneous administration of Eprex®(epoetin alfa) in patients with
chronic kidney disease (CKD) was contraindicated in the European Union between 2002 …

Pure red cell aplasia in patients who are treated for anemia of chronic kidney disease with
erythropoiesis-stimulating agents such as epoetin was first reported in 1998. Although the …

Background Anemia is present in 30–65% in cats with chronic kidney disease (CKD) and
few long‐term treatment options exist. Darbepoetin is effective in treating anemia of kidney …

Roxadustat (Rox), a hypoxia-inducible factor (HIF) stabilizer, is now available for the
treatment of anemia in hemodialysis (HD) patients. To investigate hematopoietic effect and …